Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells

Published:2018-08-06 Issue:2 Volume:183 Page:196-211
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Paulus Aneel¹,Manna Alak¹,Akhtar Sharoon¹,Paulus Shumail M.²,Sharma Mayank³,Coignet Marie V.⁴,Jiang Liuyan⁵,Roy Vivek²,Witzig Thomas E.⁶⁷,Ansell Stephen M.⁶,Allan John⁸,Furman Richard⁸,Aulakh Sonikpreet²,Manochakian Rami²,Ailawadhi Sikander²^ORCID,Chanan-Khan Asher A.¹²,Sher Taimur²

Affiliation:

1. Department of Cancer Biology; Mayo Clinic; Jacksonville FL USA

2. Division of Hematology and Medical Oncology; Mayo Clinic; Jacksonville FL USA

3. Division of Gastroenterology and Hepatology; Mayo Clinic; Rochester MN USA

4. Department of Cancer Prevention and Control; Roswell Park Cancer Institute; Buffalo NY USA

5. Department of Laboratory Medicine and Pathology; Mayo Clinic; Jacksonville FL USA

6. Division of Hematology; Mayo Clinic; Rochester MN USA

7. Division of Hematopathology; Mayo Clinic; Rochester MN USA

8. Department of Medicine; Weill Cornell Medical College; Cornell NY USA

Funder

Mayo Clinic

University of Iowa

Daniel Foundation of Alabama

Predolin Foundation (Asher Chanan-Khan)

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15515/fullpdf

Reference50 articles.

1. Preclinical models of Waldenstrom's macroglobulinemia and drug resistance;Ailawadhi;Best Practice & Research: Clinical Haematology,2016

2. Clonal B cells in Waldenstrom's macroglobulinemia exhibit functional features of chronic active B-cell receptor signaling;Argyropoulos;Leukemia,2016

3. Antibody-dependent cellular cytotoxicity activity of a novel anti-PD-L1 antibody avelumab (MSB0010718C) on human tumor cells;Boyerinas;Cancer Immunology Research,2015

4. Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma;Chiron;Cancer Discovery,2014

5. Development and characterization of a novel human Waldenstrom macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenstrom Macroglobulinemia 1;Chitta;Leukemia and Lymphoma,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström Macroglobulinemia;Current Hematologic Malignancy Reports;2024-07-06

2. BTK Inhibitors and Other Targeted Therapies in Waldenström Macroglobulinemia;Hemato;2023-04-13

3. AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma;Cancers;2023-01-12

4. Review of daratumumab efficacy in all monoclonal gammopathies and other diseases and our experience with daratumumab, lenalidomide and dexamethasone therapy in 74 patients;Onkologie;2022-10-14

5. Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy;Clinical Cancer Research;2022-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3